Abstract:Two novel mononuclear palladium(II) complexes, [PdL1Cl]Cl (1) and [PdL2Cl]Cl (2) with SNS-donor ligands (where L1= N-(4-(benzo[d]oxazol-2-yl)phenyl)-2-(bis(2-ethylthioethyl)amino)acetamide, L2 = N-(4-(benzo[d]thiazol)-2-yl)phenyl)-2-(bis(2-ethylthioethyl)amino)acetamide), were synthesized and characterized. In vitro antiproliferative activity tests showed that the two palladium(II) complexes displayed excellent antiproliferative activity against all the tested cancer cell lines, especially the human colon cancer HCT-116, the human liver cancer HepG-2, and the human breast cancer MDA-MB-231 cells. Spectacularly, complexes 1 and 2 exhibited an approximate 8.49- and 6.88-fold higher antiproliferative activity as compared with cisplatin against HCT-116, respectively, but were less toxic to the human normal colon fibroblast CCD-18Co cell lines with the selectivity index (SI  IC50(CCD-18Co)/IC50(HCT-116)) values of 22.43 and 21.48 for 1 and 2, respectively, compared to cisplatin (SI, 1.74). The results suggested that the two palladium complexes have the potential to act as a candidate for the treatment of colorectal cancer. The interaction of the complexes with CT-DNA illustrated that both 1 and 2 could strongly bind to the DNA helix via intercalative mode and covalent interaction and DNA binding affinity of 1 was slightly higher than that of 2. Additionally, investigations of the reaction of the two complexes with 5-GMP and glutathione (GSH) showed that both 1 and 2 could readily react with 5-GMP and GSH to form the Pd-GMP adducts and the Pd-GS adducts, respectively, and when 5-GMP and GSH coexisted, the coordination binding of the complexes with GSH did not prevent the formation of the Pd-GMP adducts. Moreover, Hoechst 33342 staining and flow cytometry analysis demonstrated that the two palladium(II) complexes arrested the HCT-116 cells mainly at the G2/M phase, induced mitochondrial membrane depolarization, increased ROS generation, and triggered obvious cell apoptosis.

Two New Strandberg Type Molybdophenylphosphonate Complexes: Crystal Structures and Anti-Pancreatic Cancer Activity

Two Metal–Organic Coordination Polymers Based on Polypyridyl Ligands: Crystal Structures and Inhibition of Human Spinal Tumour Cells

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Synthesis and anticancer activities of novel Pt (II) and Pd (II) complexes with 4‐(2,2′:6′,2′′‐terpyridin‐4′‐yl)phenol as ligand

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Molybdenum (VI) Complexes and their Dual Role as Antidiabetic and Anticancer Agents

The copper(II) complexes of new anthrahydrazone ligands: In vitro and in vivo antitumor activity and structure-activity relationship

Two new lanthanide complexes with 5-(Pyrazol-1-yl)nicotinic acid: Structures and their anti-cancer properties

Two binuclear copper(II) complexes incorporated with 3-phenylpentanedioic acid: crystal structure and bioactivity characteristics

Synthesis and anticancer property of two Sm(III) compounds based on tetrazole ligands

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Bifunctional tetrazole–carboxylate ligand based Zn(II) complexes: synthesis and their excellent potential anticancer properties

Bio-physical and theoretical investigations on Pt(II)-pyridine based complexes with relevant bio-molecules for the development of potent anticancer drug candidates

Synthesis, characterization, crystal structures and biological activity of molybdenum complexes derived from bis(acetylacetonato)dioxomolybdenum(VI) and Schiff bases

Synthesis, characterization, and cytotoxicity of Pt (II) and Pd (II) complexes with 2-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline as ligand

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2)

Cu(II) and Zn(II) complexes incorporated with active analogue fragments molecule of the aristolochic acid: Crystal structure and biological activity

Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications

Two novel SNS-donor palladium(II) complexes of benzoxazole and benzothiazole derivatives as potential anticancer agentsPlease do not adjust margins

Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl) phenyl)-1H-1,2,4-triazol-5(4H)-one